impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Full Papers

 

Evaluation of the Coping Strategies Questionnaire-Revised for fatigue in systemic sclerosis: a Scleroderma Patient-centred Intervention Network (SPIN) cohort study

1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
Collaborator/s: C.E. Adams1, C. Agard2, L. Alric3, M. André4, F. Beaslay5, E.J. Bernstein6, S. Berthier7, L. Bissonnette8, S. Blaise9, E. Bories10, A. Bruns11, C. Cacciatore12, P. Carreira13, M. Casadevall14, B. Chaigne15, L. Chung16, B. Crichi17, T. Deltombe18, C.P. Denton19, T. Desroche20, R. Domsic21, J.V. Dunne22, B. Dunogue23, R. Fare24, D. Farge-Bancel25, P.R. Fortin26, T. Frech27, L. Gauzère28, A. Gerber29, J.K. Gordon30, B. Granel-Rey31, A. Guffroy32, G. Gyger33, E. Hachulla34, M. Hinchcliff35, S. Hoa36, M. Hughes37, A. Ikic38, S.R. Johnson39, N. Khalidi40, K.S. Lakin41, M. Lambert42, M. Larche43, D. Launay44, Y.C. Lee45, P. Legendre46, C. Leite47, H. Maillard48, N. Maltez49, J. Manning50, I. Marie51, M. Martin Lopez52, T. Martin53, A. Masetto54, A. Mekinian55, S. Melchor Díaz56, M. Mourguet57, C. Nguyen58, K. Nielsen59, M. Nikpour60, L. Olagne61, V. Poindron62, J. Pope63, S. Proudman64, G. Pugnet65, L. Raffray66, F. Rannou67, A. Régent68, F. Renou69, S. Rivière70, D. Robinson71, E. Rodríguez Almazar72, T.S. Rodriguez-Reyna73, S. Roux74, P. Smets75, V. Sobanski76, R.F. Spiera77, V. Steen78, E. Sutton79, C. Thorne80, D. Vagner81, J. Varga82, P. Wilcox83, R.K. Wojeck84, M. Cañedo Ayala85, N. Co86, V. Cook87, T. Dal Santo88, M. D'onofrio89, S. Hu90, E.-L. Nassar91, M.A. Neyer92, G. Pierson93, S. Provencher94

 

  1. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, and Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
  2. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  3. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  4. Department of Applied Statistics, Social Science, and Humanities, New York University, New York, NY, USA.
  5. Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen; Department of IQ Health, Radboud University Medical Center, Nijmegen; and Centre for Mindfulness, Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands.
  6. Department of Medicine, McGill University, Montreal, and Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.
  7. Ottawa Scleroderma Support Group, Ottawa, Ontario, Canada.
  8. National Scleroderma Foundation, Tri-State Chapter, Buffalo, NY, USA.
  9. National Scleroderma Foundation, Los Angeles, CA, USA.
  10. Sclérodermie Québec, Longueuil, Quebec, Canada.
  11. Scleroderma Australia, Melbourne, and Scleroderma Victoria, Melbourne, Victoria, Australia.
  12. Scleroderma Atlantic, Halifax, Nova Scotia, Canada.
  13. Scleroderma Society of Ontario, Hamilton, and Scleroderma Canada, Hamilton, Ontario, Canada.
  14. Service de Médecine Interne, Centre de Référence Maladies Autoimmunes et Autoinflammatoires Systémiques Rares d'Ile de France, de l’Est et de l’Ouest, Hôpital Cochin, Paris, and Assistance Publique Hôpitaux de Paris-Centre, Hôpital Cochin, Université Paris Cité, Paris, France.
  15. Department of Psychology, San Diego State University, San Diego, CA, and San Diego State University and University of California, San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
  16. Department of Medicine, McGill University, Montreal, Quebec; Research Institute of the McGill University Health Centre, Montreal, Québec; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec; and Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Québec, Canada.
  17. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca

  1. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  2. Centre Hospitalier Universitaire Hôtel-Dieu de Nantes, Nantes, France.
  3. CHU Rangueil, Toulouse, France.
  4. Centre Hospitalier Universitaire Gabriel-Montpied, Clermont-Ferrand, France.
  5. CHU La Réunion, Saint-Denis, La Réunion, France.
  6. Columbia University, New York, NY, USA.
  7. Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.
  8. Université de Sherbrooke, Quebec, Canada.
  9. CHU Grenoble Alpes, Grenoble, France.
  10. CHU Rangueil, Toulouse, France.
  11. Université de Sherbrooke, Quebec, Canada.
  12. Assistance Publique, Hôpitaux de Paris, Hôpital St-Louis, Paris, France.
  13. Servicio de Reumatologia del Hospital 12 de Octubre, Madrid, Spain.
  14. Assistance Publique, Hôpitaux de Paris, Hôpital Cochin, Paris, France.
  15. Assistance Publique, Hôpitaux de Paris, Hôpital Cochin, Paris, France.
  16. Stanford University, Stanford, CA, USA.
  17. Assistance Publique, Hôpitaux de Paris, Hôpital St-Louis, Paris, France.
  18. CHU La Réunion, Saint-Denis, La Réunion, France.
  19. Royal Free London Hospital, London, UK.
  20. CHU La Réunion, Saint-Denis, La Réunion, France
  21. University of Pittsburgh, PA, USA.
  22. St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
  23. Assistance Publique, Hôpitaux de Paris, Hôpital Cochin, Paris, France.
  24. Servicio de Reumatologia del Hospital 12 de Octubre, Madrid, Spain.
  25. Assistance Publique, Hôpitaux de Paris, Hôpital St-Louis, Paris, France.
  26. CHU de Québec, Université Laval, Quebec, Canada.
  27. Vanderbilt University, Nashville, TN, USA.
  28. CHU La Réunion, Saint-Denis, La Réunion, France.
  29. CHU La Réunion, Saint-Denis, La Réunion, France.
  30. Hospital for Special Surgery, New York, NY, USA.
  31. Université, and Assistance Publique, Hôpitaux de Marseille, Hôpital Nord, Marseille, France.
  32. Les Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, Strasbourg, France.
  33. Jewish General Hospital and McGill University, Montreal, Quebec, Canada.
  34. Centre Hospitalier Régional Universitaire de Lille, Hôpital Claude Huriez, Lille, France.
  35. Yale School of Medicine, New Haven, CT, USA.
  36. Centre Hospitalier de l’Université de Montréal, CHUM, Montreal, Quebec, Canada.
  37. Salford Royal NHS Foundation Trust, Salford, UK.
  38. Université Laval, CHU de Québec, Canada.
  39. Toronto Scleroderma Program, Mount Sinai Hospital, Toronto Western Hospital, and University of Toronto, Toronto, Ontario, Canada.
  40. McMaster University, Hamilton, Ontario, Canada.
  41. Hospital for Special Surgery, New York, NY, USA.
  42. Centre Hospitalier Régional Universitaire de Lille, Hôpital Claude Huriez, Lille, France.
  43. McMaster University, Hamilton, Ontario, Canada.
  44. Centre Hospitalier Régional Universitaire de Lille, Hôpital Claude Huriez, Lille, France.
  45. Northwestern University, Chicago, IL, USA.
  46. Centre Hospitalier du Mans, Le Mans, France.
  47. University of Minho, Braga, Portugal.
  48. Centre Hospitalier Régional Universitaire de Lille, Hôpital Claude Huriez, Lille, France.
  49. University of Ottawa, Ontario, Canada.
  50. Salford Royal NHS Foundation Trust, Salford, UK.
  51. CHU Rouen, Hôpital de Bois-Guillaume, Rouen, France.
  52. Servicio de Reumatologia del Hospital 12 de Octubre, Madrid, Spain.
  53. Les Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, Strasbourg, France.
  54. Université de Sherbrooke, Quebec, Canada.
  55. Assistance Publique, Hôpitaux de Paris, Hôpital St-Antoine, Paris, France.
  56. Servicio de Reumatologia del Hospital 12 de Octubre, Madrid, Spain.
  57. CHU Rangueil, Toulouse, France.
  58. Université Paris Descartes, Université de Paris, and Assistance Publique, Hôpitaux de Paris, France.
  59. Scleroderma Society of Ontario, Hamilton, Ontario, Canada.
  60. St Vincent’s Hospital and University of Melbourne, Melbourne, Victoria, Australia.
  61. Centre Hospitalier Universitaire Gabriel-Montpied, Clermont-Ferrand, France.
  62. Les Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, Strasbourg, France.
  63. University of Western Ontario, London, Ontario, Canada.
  64. Royal Adelaide Hospital and University of Adelaide, South Australia, Australia.
  65. CHU Rangueil, Toulouse, France.
  66. CHU La Réunion, Saint-Denis, La Réunion, France.
  67. Université Paris Descartes, Université de Paris, and Assistance Publique, Hôpitaux de Paris, France.
  68. Assistance Publique, Hôpitaux de Paris, Hôpital Cochin, Paris, France.
  69. CHU La Réunion, Saint-Denis, La Réunion, France.
  70. Assistance Publique, Hôpitaux de Paris, Hôpital St-Antoine, Paris, France.
  71. University of Manitoba, Winnipeg, Manitoba, Canada.
  72. Servicio de Reumatologia del Hospital 12 de Octubre, Madrid, Spain.
  73. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  74. Université de Sherbrooke, Quebec, Canada.
  75. Centre Hospitalier Universitaire Gabriel-Montpied, Clermont-Ferrand, France.
  76. Centre Hospitalier Régional Universitaire de Lille, Hôpital Claude Huriez, Lille, France.
  77. Hospital for Special Surgery, New York, NY, USA.
  78. Georgetown University, Washington, DC, USA.
  79. Dalhousie University, Halifax, Nova Scotia, Canada.
  80. Southlake Regional Health Centre, Newmarket, Ontario, Canada.
  81. CHU La Réunion, Saint-Denis, La Réunion, France.
  82. University of Michigan, Ann Arbor, MI, USA.
  83. St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
  84. Amgen Inc, Thousand Oaks, CA, USA.
  85. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  86. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  87. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  88. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  89. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  90. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  91. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  92. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  93. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  94. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

on behalf of the SPIN Investigators

CER18324
Full Papers

purchase article

PMID: 40095633 [PubMed]

Received: 11/11/2024
Accepted : 21/02/2025
In Press: 10/03/2025

Abstract

OBJECTIVES:
To adapt and evaluate the Coping Strategies Questionnaire-Revised (CSQ-R), designed to assess pain coping, for assessing coping with fatigue in systemic sclerosis (SSc).
METHODS:
We adapted CSQ-R items for fatigue, and a panel of people with SSc verified content validity. Scleroderma Patient-centred Intervention Network Cohort participants completed the CSQ-R-Fatigue. We evaluated factor structure with confirmatory factor analysis (CFA), assessed differential item functioning (DIF) by English and French language and disease subtype, and evaluated internal consistency and test-retest reliability.
RESULTS:
863 participants were included. Most were female (n=756; 88%), and 36% (n=308) had diffuse SSc. We replicated the 6-factor CSQ-R structure (Tucker-Lewis Index =0.95, Comparative Fit Index =0.97, Root Mean Square Error of Approximation =0.05). We found substantive DIF across multiple factors, however, for language and disease subtype (11 items on 6 factors for language, 10 items on 5 factors for subtype). Factor-score differences due to DIF by language and subtype were ≥0.20 standardised mean differences for 4 factors each. Test-retest reliability for factors based on intraclass correlation was between 0.68 [95% CI 0.58, 0.76] and 0.91 [95% CI 0.88, 0.93]; n=183.
CONCLUSIONS:
The CSQ-R-Fatigue may not be appropriate to assess coping with fatigue in SSc due to possible biases related to language and disease severity. An additional concern is that the CSQ-R-Fatigue focuses on psychological coping and does not assess active coping strategies. Research is needed to identify or develop tools to evaluate coping strategies for managing fatigue in SSc.

DOI: https://doi.org/10.55563/clinexprheumatol/26zipq

Rheumatology Article

Rheumatology Addendum